Chinese medicine Lianhua Qingwen not approved for COVID-19: HSA


Source: singaporenewslive.com singaporenewslive.com

Key Topics in this News Article:

News Snapshot:

SINGAPORE: Chinese medicine Lianhua Qingwen is not approved for the treatment of COVID-19 symptoms, said the Health Sciences Authority (HSA) on Wednesday (Nov 17), adding that such claims are disallowed. In an advisory, HSA said it is aware of claims circulating on social media and in Telegram chat groups that Lianhua Qingwen products can be used to prevent or treat COVID-19. “Some Lianhua Qingwen products are listed as Chinese proprietary medicines in Singapore for the relief of cold and flu symptoms. HSA approved them based on the documented uses of the ingredients present in the products,” said the authority. “To...